{"transactions":[{"id":4026488,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":5901,"price":8.263,"value":48759.963,"ownership":{"direct":false,"nature":"Owned by Michael D. Kazma, manager of Amzak Capital Management, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}},{"id":4026487,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-27","kind":"sale","acquired":false,"shares":80880,"price":8.357,"value":675914.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.25 to $8.61, inclusive. The Reporting Persons undertake to provide to Zosano Pharma Corp. (\"Zosano\"), any security holder of Zosano, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnotes (2) and (3) of this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person."}],"balance_after":175211,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}},{"id":4026486,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":168879,"kind":"organization","name":"Amzak Capital Management, LLC","position":1,"cik":"0001565981","reported_name":"Amzak Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":168880,"kind":"person","name":"Kazma Gerald J","position":3,"cik":"0001702234","reported_name":"Kazma Gerald J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value of $0.0001","published_at":"2018-02-28T17:38:55.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":1500,"price":11,"value":16500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported as directly beneficially owned by the Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed on this Form 4, each of whom is a manager of the Reporting Person."}],"balance_after":256091,"source":{"system":"sec-edgar","filing":"0001213900-18-002426","document":"f4022618amzak_zosanopharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1565981/000121390018002426/f4022618amzak_zosanopharma.xml","form_type":"4"}}]}